COMMUNIQUÉS West-GlobeNewswire

Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14/02/2025
SAN FRANCISCO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein [...]
Fate Therapeutics to Present at Upcoming Investor Conferences
14/02/2025
SAN DIEGO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)- [...]
Entero Therapeutics Appoints Richard Paolone as CEO
14/02/2025
BOCA RATON, Fla., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc. (Nasdaq: ENTO) (“Entero” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non- [...]
MEDIA ADVISORY - Patients who have been extra-billed for surgeries in private for-profit clinics demand accountability in the Ontario election: Press conferences in towns across Ontario
14/02/2025
TORONTO, OTTAWA, LONDON and WINDSOR, Ontario, Feb. 14, 2025 (GLOBE NEWSWIRE) -- The Ontario Health Coalition is holding press conferences with patients who have been charged for cataract surgeries or manipulated into [...]
New AI-Powered Startup Merges Technology and Holistic Wellness to Deliver Personalized Health Solutions
14/02/2025
New York, NY, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Samantha Williams , a professional runway and print magazine model for brands like Chi, today announced the launch of the waitlist for YOU Wellness, a new wellness [...]
Turmeric Hack: The 15-Second Morning Ritual Transforming Weight Loss, Backed by Doctor Julian Ross
14/02/2025
LAKELAND, Fla., Feb. 14, 2025 (GLOBE NEWSWIRE) -- A new, turmeric hack is rapidly reshaping the weight-loss conversation, offering a potential breakthrough for those who’ve tried (and failed) with traditional approaches [...]
PetVivo Reports Fiscal Q3 2025 Results
14/02/2025
MINNEAPOLIS, MN, US, Feb. 14, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW), a leading biomedical company delivering innovative therapeutics and medical devices for equines and companion [...]
Tevogen Bio Shares 2024 Financing Activity on One Year Anniversary of Becoming a Publicly Listed Company; Highlights Operational Efficiency
14/02/2025
WARREN, N.J., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech company, shares a summary of the Company’s 2024 [...]
Zus Health Celebrates Unprecedented Growth, Announcing New Clients and AI-Powered Innovations
14/02/2025
BOSTON, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Zus Health is proud to announce a transformative milestone in its journey to reshape care delivery through data interoperability and actionable insights. Over the past year, Zus [...]
Tevogen Bio CEO Addresses Short Selling and Its Potential Impact on the Nation’s Health and Prosperity
14/02/2025
WARREN, N.J., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech company, today issued a statement from its Founder [...]
AVITA Medical to Host Investor Webinar Briefing
14/02/2025
VALENCIA, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders and prospective [...]
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
14/02/2025
ORION CORPORATION STOCK EXCHANGE RELEASE – MAJOR SHAREHOLDER ANNOUNCEMENTS 14 FEBRUARY 2025 at 16.15 EET Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]
Longeveron to Present at the Emerging Growth Virtual Conference on February 19, 2025
14/02/2025
MIAMI, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related [...]
Ensho Therapeutics Announces Upcoming Presentation at ECCO 2025 of Phase 1, Once-Daily Dosing Data for NSHO-101, an Oral α4β7 Inhibitor for Inflammatory Bowel Disease
14/02/2025
MORRIS PLAINS, N.J., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Ensho Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company focused on developing breakthrough oral therapies for patients with [...]
IN8bio Presents Positive Phase 1 Data at TCT 2025, Highlighting Durability of Remissions in High-Risk AML
14/02/2025
NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- February 14, 2025 – IN8bio, Inc . (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, yesterday presented Phase 1 [...]
Artelo Biosciences Announces New Data on ART12.11 Tablets Showing Improved Pharmacokinetics to Epidiolex®
14/02/2025
SOLANA BEACH, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people [...]
OraSure to Announce Fourth Quarter 2024 Financial Results and Host Earnings Call on February 25th
14/02/2025
BETHLEHEM, Pa., Feb. 14, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering fourth quarter 2024 financial results and certain business [...]
Sienna Announces February Dividend
14/02/2025
MARKHAM, Ontario, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “ Common Share ”) [...]
Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update
14/02/2025
-Fifth Subject in BB-301 Phase 1b/2a Clinical Treatment Study safely treated in February 2025- -Interim clinical study update to be presented in late-breaking oral presentation at the 2025 Muscular Dystrophy Association [...]

Pages